Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Eternygen raises €8mm in Series A round; includes investment from partner Evotec

Executive Summary

Eternygen GMBH (metabolic disease focused biopharma) raised €8mm ($8.3mm) in its Series A financing round led by Epidarex Capital, along with VC Founds Technologie (managed by IBB Beteiligungsgesellschaft), and two family offices. The round also includes participation from partner Evotec AG.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register